Last month, IceCure Medical’s tumor-freezing technology won FDA approval for treating early-stage breast cancer. Now, the Israel-based medtech is touting a new study showing its procedure combined with radiation may extend survival for patients with an inoperable form of lung cancer.
<a href="https://www.fiercebiotech.com/medtech/icecures-cryoablation-treatment-may-extend-survival-some-lung-cancer-patients-study-finds" hreflang="en">IceCure's cryoablation treatment may extend survival in some lung cancer patients, study finds</a>
FierceBiotech | | Natalie Missakian
Topics: breast-cancer, lung-cancer, breakthrough-drugs, new-technology, research